Adagene Inc.
ADAG
$1.64
$0.000.00%
Weiss Ratings | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.06 | |||
Price History | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | -19.61% | |||
60-Day Total Return | -17.17% | |||
90-Day Total Return | -21.53% | |||
Year to Date Total Return | -20.39% | |||
1-Year Total Return | -43.45% | |||
2-Year Total Return | 21.48% | |||
3-Year Total Return | -56.61% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -54.20% | |||
52-Week Low % Change | 23.77% | |||
Price | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $3.58 | |||
52-Week Low Price | $1.33 | |||
52-Week Low Price (Date) | Apr 01, 2025 | |||
52-Week High Price (Date) | Sep 16, 2024 | |||
Valuation | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 77.26M | |||
Enterprise Value | 10.56M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.93 | |||
Earnings Per Share Growth | 70.12% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 585.71 | |||
Price/Book (Q) | 1.22 | |||
Enterprise Value/Revenue (TTM) | 102.31 | |||
Price | $1.64 | |||
Enterprise Value/EBITDA (TTM) | -0.30 | |||
Enterprise Value/EBIT | -0.29 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 36.71M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 86 512 8777 3632 | |||
Address | -- | |||
Website | www.adagene.com | |||
Country | China | |||
Year Founded | 2011 | |||
Profitability | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -34,836.82% | |||
Profit Margin | -32,387.79% | |||
Management Effectiveness | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -21.92% | |||
Return on Equity | -- | |||
Income Statement | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 103.20K | |||
Total Revenue (TTM) | 103.20K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | 103.20K | |||
EBITDA (TTM) | -35.23M | |||
EBIT (TTM) | -35.95M | |||
Net Income (TTM) | -33.42M | |||
Net Income Avl. to Common (TTM) | -33.42M | |||
Total Revenue Growth (Q YOY) | -87.35% | |||
Earnings Growth (Q YOY) | -10.61% | |||
EPS Diluted (TTM) | -0.93 | |||
EPS Diluted Growth (Q YOY) | -5.77% | |||
Balance Sheet | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 85.19M | |||
Cash Per Share (Q) | $2.32 | |||
Total Current Assets (Q) | 87.78M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 50.52M | |||
Current Ratio (Q) | 2.299 | |||
Book Value Per Share (Q) | $1.34 | |||
Total Assets (Q) | 89.27M | |||
Total Current Liabilities (Q) | 38.18M | |||
Total Debt (Q) | 18.49M | |||
Total Liabilities (Q) | 38.74M | |||
Total Common Equity (Q) | 50.52M | |||
Cash Flow | ADAG - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 1.11M | |||
Cash from Financing (TTM) | 3.77M | |||
Net Change in Cash (TTM) | -24.74M | |||
Levered Free Cash Flow (TTM) | -18.87M | |||
Cash from Operations (TTM) | -29.70M | |||